Outcome of Patients After Total Knee Replacement: A Comparison of Femoral Nerve Block and Epidural Anesthesia
Outcome of Patients After Total Knee Replacement: A Comparison of Femoral Nerve Block and Epidural Anesthesia. A Randomized, Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Mecklenburg/Vorpommern
-
Rostock, Mecklenburg/Vorpommern, Germany, 18057
- University of Rostock
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18 -80 years
- ASA I-III
- Surgery: total knee replacement
- informed consent
Exclusion Criteria:
- obesity
- contraindication for epidural anesthesia
- coagulation disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Femoral Block
One group received a femoral block for analgesia after surgery.
Ropivacain was administered continuously for three days.
|
Femoral catheter was inserted at the beginning of surgery.
After surgery ropivacaine was administered continuously for three days.
In addition, patients received piritramide via patient-controlled analgesia.
The amount of ropivacaine was measured.
|
|
ACTIVE_COMPARATOR: Epidural Analgesia
One group received an epidural analgesia after surgery for three days.
|
The epidural catheter was inserted at the beiginning of surgery.
After surgery ropivacaine was applied continuously for three days.
In addition, patients received piritramide via patient controlled analgesia.
The amount of ropivacaine was measured.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Function
Time Frame: 3 months after surgery
|
3 months after surgery the function of the total knee replacement is testd
|
3 months after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality
Time Frame: 28 days after surgery
|
28 days after surgery
|
|
Morbidity
Time Frame: 28 days after surgery
|
28 days after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Thomas Mencke, PD Dr., Dep. of Anesthesia, University of Rostock
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- A 40 2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.